Perianal fistulising Crohn disease-associated malignancy: a multi-institutional study of histology, clinical features, and outcomes
Pathology · 2026-06 · 58 (4) · 393-398
DOI: 10.1016/j.pathol.2026.01.364 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pathology, 2026-06. Verfasst von Pooja Navale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cooper University Heath Care, Camden, NJ, USA. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Perianal fistulising Crohn's disease (CD) is a debilitating complication of CD. Malignancies arising in this setting are rare and challenging to diagnose. In this study, we aimed to characterise the clinical, pathologic, and outcome features of perianal CD fistula-related malignancies (PCDFMs). We conducted a multi-institutional retrospective study (between 2005 and 2023) querying pathology databases of six academic centres for PCDFM. Only cancers arising in perianal fistulising CD were included. Clinical, imaging, pathologic, and follow-up data were collected and analysed. A total of 32 patients (19 males and 13 females) were identified. The median age at diagnosis was 53.6 years (range 30-74). Median duration of CD and fistula was 300 months (range 96-684) and 53 months (range 3-564), respectively. Thirty-one of 32 (96.9%) were symptomatic. Imaging was available in 27 patients (84.4%) and was abnormal in all cases. Serum carcinoembryonic antigen levels were available in 17 patients, of which 8 (47.1%) were elevated. Histologically, 26 cases (81.3%) were adenocarcinomas and 6 (18.8%) were squamous cell carcinomas. Twenty-three patients underwent resections, and 27 received chemotherapy with or without radiation. Pathologic staging was available in 19 patients: three had T4 disease, four had nodal disease, and one had distant metastasis. Median follow-up among 27 patients was 9 months. Four patients developed recurrence, four developed metastasis, and six (22.2%) died of disease. T4 stage and nodal disease correlated with higher disease-specific mortality. PCDFM arises in long-standing CD, usually presents symptomatically with abnormal anorectal imaging, and most often manifests as adenocarcinoma. Outcomes are stage dependent, underscoring the need for early recognition and multidisciplinary management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Cooper University Heath Care, Camden, NJ, USA.
- Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
- Department of Pathology, University of California, San Francisco, CA, USA.
- Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Pathology, University of Chicago, Chicago, IL, USA.
Zitieren
APA
Navale, P., Toro, P., Hu, S., Wen, K. W., Liao, X., Zhang, D., Alpert, L., & Liu, X. (2026). Perianal fistulising Crohn disease-associated malignancy: a multi-institutional study of histology, clinical features, and outcomes. Pathology, 58(4), 393-398. https://doi.org/10.1016/j.pathol.2026.01.364
Vancouver
Navale P, Toro P, Hu S, Wen KW, Liao X, Zhang D, et al. Perianal fistulising Crohn disease-associated malignancy: a multi-institutional study of histology, clinical features, and outcomes. Pathology. 2026;58(4):393-398. doi:10.1016/j.pathol.2026.01.364
BibTeX
@article{Navale2026,
author = {Navale, Pooja and Toro, Paula and Hu, Shaomin and Wen, Kwun Wah and Liao, Xiaoyan and Zhang, Dongwei and Alpert, Lindsay and Liu, Xiuli},
title = {Perianal fistulising Crohn disease-associated malignancy: a multi-institutional study of histology, clinical features, and outcomes},
journal = {Pathology},
year = {2026},
volume = {58},
number = {4},
pages = {393--398},
doi = {10.1016/j.pathol.2026.01.364}
}
EUVIMED